The WACC of LHC Group Inc (LHCG) is 8.8%.
Range | Selected | |
Cost of equity | 7.8% - 10.8% | 9.3% |
Tax rate | 22.1% - 22.5% | 22.3% |
Cost of debt | 4.9% - 8.4% | 6.65% |
WACC | 7.4% - 10.3% | 8.8% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.85 | 1.06 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.8% | 10.8% |
Tax rate | 22.1% | 22.5% |
Debt/Equity ratio | 0.13 | 0.13 |
Cost of debt | 4.9% | 8.4% |
After-tax WACC | 7.4% | 10.3% |
Selected WACC | 8.8% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
LHCG | LHC Group Inc | 0.13 | 0.44 | 0.4 |
AMED | Amedisys Inc | 0.12 | 0.16 | 0.15 |
AMEH | Apollo Medical Holdings Inc | 0.11 | 1.21 | 1.12 |
ENZ | Enzo Biochem Inc | 0.01 | 1.9 | 1.88 |
MD | MEDNAX Inc | 0.55 | 0.64 | 0.45 |
ONEM | 1Life Healthcare Inc | 0.09 | 0.98 | 0.92 |
OPCH | Option Care Health Inc | 0.23 | 0.44 | 0.37 |
PTQ.V | Protech Home Medical Corp | 0.15 | 1.94 | 1.74 |
RDNT | RadNet Inc | 0.24 | 1.06 | 0.89 |
WELL.TO | WELL Health Technologies Corp | 0.4 | 1.86 | 1.42 |
Low | High | |
Unlevered beta | 0.71 | 1 |
Relevered beta | 0.78 | 1.09 |
Adjusted relevered beta | 0.85 | 1.06 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for LHCG:
cost_of_equity (9.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.85) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.